{"id":"https://openalex.org/W4365512192","doi":"https://doi.org/10.1158/1538-7445.am2023-lb346","title":"Abstract LB346: Mapping of shared tumor antigen reactivity with nanoparticle encapsulated mRNA in prostate cancer patients","display_name":"Abstract LB346: Mapping of shared tumor antigen reactivity with nanoparticle encapsulated mRNA in prostate cancer patients","publication_year":2023,"publication_date":"2023-04-14","ids":{"openalex":"https://openalex.org/W4365512192","doi":"https://doi.org/10.1158/1538-7445.am2023-lb346"},"language":"en","primary_location":{"id":"doi:10.1158/1538-7445.am2023-lb346","doi":"https://doi.org/10.1158/1538-7445.am2023-lb346","is_oa":false,"landing_page_url":"http://dx.doi.org/10.1158/1538-7445.am2023-lb346","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5006554870","display_name":"Elena I Montauti","orcid":"https://orcid.org/0000-0002-7760-2830","observed_orcids":["https://orcid.org/0000-0002-7760-2830"]},"institutions":[{"id":"https://openalex.org/I180670191","display_name":"University of California, San Francisco","ror":"https://ror.org/043mz5j54","country_code":"US","type":"education","lineage":["https://openalex.org/I180670191"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Elena Montauti","raw_affiliation_strings":["1UCSF - University of California San Francisco, San Francisco, CA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1UCSF - University of California San Francisco, San Francisco, CA;","institution_ids":["https://openalex.org/I180670191"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5016794685","display_name":"Ole Audun Werner Haabeth","orcid":"https://orcid.org/0000-0002-1153-9250","observed_orcids":["https://orcid.org/0000-0002-1153-9250"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Ole Haabeth","raw_affiliation_strings":["2Nutcracker Therapeutics, Emeryville, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Nutcracker Therapeutics, Emeryville, CA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5033929393","display_name":"Chris S. Rae","orcid":"https://orcid.org/0009-0005-4583-5647","observed_orcids":["https://orcid.org/0009-0005-4583-5647"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Chris Rae","raw_affiliation_strings":["2Nutcracker Therapeutics, Emeryville, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Nutcracker Therapeutics, Emeryville, CA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5084583146","display_name":"Samuel Deutsch","orcid":"https://orcid.org/0000-0001-9456-7101","observed_orcids":["https://orcid.org/0000-0001-9456-7101"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Samuel Deutsch","raw_affiliation_strings":["2Nutcracker Therapeutics, Emeryville, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Nutcracker Therapeutics, Emeryville, CA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5073970384","display_name":"Lawrence H. Fong","orcid":"https://orcid.org/0000-0002-6428-428X","observed_orcids":["https://orcid.org/0000-0002-6428-428X"]},"institutions":[{"id":"https://openalex.org/I180670191","display_name":"University of California, San Francisco","ror":"https://ror.org/043mz5j54","country_code":"US","type":"education","lineage":["https://openalex.org/I180670191"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Lawrence Fong","raw_affiliation_strings":["1UCSF - University of California San Francisco, San Francisco, CA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1UCSF - University of California San Francisco, San Francisco, CA;","institution_ids":["https://openalex.org/I180670191"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5058893054","display_name":"David Yoonsuk Oh","orcid":"https://orcid.org/0000-0002-3310-0994","observed_orcids":["https://orcid.org/0000-0002-3310-0994"]},"institutions":[{"id":"https://openalex.org/I180670191","display_name":"University of California, San Francisco","ror":"https://ror.org/043mz5j54","country_code":"US","type":"education","lineage":["https://openalex.org/I180670191"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"David Oh","raw_affiliation_strings":["1UCSF - University of California San Francisco, San Francisco, CA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1UCSF - University of California San Francisco, San Francisco, CA;","institution_ids":["https://openalex.org/I180670191"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"83","issue":"8_Supplement","first_page":"LB346","last_page":"LB346"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.9829000234603882,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.9829000234603882,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.013000000268220901,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10543","display_name":"Prostate Cancer Treatment and Research","score":0.0027000000700354576,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/prostate-cancer","display_name":"prostate cancer","score":0.9829999804496765},{"id":"https://openalex.org/keywords/shared-tumor-antigens","display_name":"shared tumor antigens","score":0.7889999747276306},{"id":"https://openalex.org/keywords/ny-eso-1","display_name":"NY-ESO-1","score":0.8299999833106995},{"id":"https://openalex.org/keywords/hk2","display_name":"HK2","score":0.9879999756813049},{"id":"https://openalex.org/keywords/tmprss2-erg-fusion","display_name":"TMPRSS2-ERG fusion","score":0.9340000152587891},{"id":"https://openalex.org/keywords/cd8-t-cell-responses","display_name":"CD8+ T cell responses","score":0.843999981880188},{"id":"https://openalex.org/keywords/interferon-gamma","display_name":"interferon-gamma","score":0.921999990940094},{"id":"https://openalex.org/keywords/immunogenicity","display_name":"immunogenicity","score":0.5799999833106995},{"id":"https://openalex.org/keywords/cancer-vaccine-development","display_name":"cancer vaccine development","score":0.47600001096725464},{"id":"https://openalex.org/keywords/cold-tumors","display_name":"cold tumors","score":0.6510000228881836},{"id":"https://openalex.org/keywords/prostate-specific-antigen","display_name":"prostate-specific antigen","score":0.5260000228881836},{"id":"https://openalex.org/keywords/prostate-stem-cell-antigen","display_name":"prostate stem cell antigen","score":0.7020000219345093},{"id":"https://openalex.org/keywords/prostate-specific-membrane-antigen","display_name":"prostate-specific membrane antigen","score":0.8640000224113464},{"id":"https://openalex.org/keywords/steap1","display_name":"STEAP1","score":0.7889999747276306},{"id":"https://openalex.org/keywords/pap","display_name":"PAP","score":0.7639999985694885},{"id":"https://openalex.org/keywords/tumor-associated-antigens","display_name":"tumor-associated antigens","score":0.4129999876022339}],"concepts":[{"id":"https://openalex.org/C2779053233","wikidata":"https://www.wikidata.org/wiki/Q731235","display_name":"ELISPOT","level":4,"score":0.6870157122612},{"id":"https://openalex.org/C147483822","wikidata":"https://www.wikidata.org/wiki/Q103537","display_name":"Antigen","level":2,"score":0.6723373532295227},{"id":"https://openalex.org/C2780192828","wikidata":"https://www.wikidata.org/wiki/Q181257","display_name":"Prostate cancer","level":3,"score":0.6320350766181946},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.5781616568565369},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5585833191871643},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.49866294860839844},{"id":"https://openalex.org/C167672396","wikidata":"https://www.wikidata.org/wiki/Q417800","display_name":"CD8","level":3,"score":0.46456634998321533},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.45974475145339966},{"id":"https://openalex.org/C2776090121","wikidata":"https://www.wikidata.org/wiki/Q193529","display_name":"T cell","level":3,"score":0.4384644329547882},{"id":"https://openalex.org/C137061746","wikidata":"https://www.wikidata.org/wiki/Q736033","display_name":"Peripheral blood mononuclear cell","level":3,"score":0.4350544810295105},{"id":"https://openalex.org/C2781406297","wikidata":"https://www.wikidata.org/wiki/Q409450","display_name":"Prostate-specific antigen","level":4,"score":0.42249998450279236},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.40273869037628174},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.231929212808609},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.22039112448692322},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.13728979229927063},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/1538-7445.am2023-lb346","doi":"https://doi.org/10.1158/1538-7445.am2023-lb346","is_oa":false,"landing_page_url":"http://dx.doi.org/10.1158/1538-7445.am2023-lb346","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W3175249622","https://openalex.org/W4400094497","https://openalex.org/W1992700503","https://openalex.org/W3119821925","https://openalex.org/W7098084759","https://openalex.org/W2266460475","https://openalex.org/W2240917718","https://openalex.org/W4224326620","https://openalex.org/W2083387364","https://openalex.org/W2107670985"],"abstract_inverted_index":{"Abstract":[0],"Background:":[1],"Prostate":[2],"cancer":[3,15,286,304,379],"(PC)":[4],"remains":[5],"refractory":[6],"immune":[7,98],"checkpoint":[8],"therapies":[9,350],"(CPT)":[10],"despite":[11],"having":[12],"an":[13,192,301],"FDA-approved":[14],"vaccine.":[16],"PC":[17,51,69,107,112,135,167,225,231,329],"is":[18,52,71],"known":[19],"to":[20,54,93,100,123,138,175,209,217,228,245,277,292,299,323,339],"have":[21],"a":[22,42,56,86,102,283,309],"low":[23,28],"mutation":[24],"burden":[25],"resulting":[26],"in":[27,47,68,106,266,295,311,331,347,377],"level":[29],"of":[30,45,64,88,104,147,166,194,214,224,237,241,256,261,285,313,327,368,384],"neoantigens,":[31],"so":[32],"shared":[33,328,369],"tumor":[34,65,370],"associated":[35],"antigens":[36,46],"(TAAs)":[37],"and":[38,62,82,121,153,161,182,288,335,398],"translocations":[39],"presumably":[40],"represent":[41],"dominant":[43],"source":[44],"this":[48],"disease.":[49],"While":[50],"thought":[53],"be":[55,275,300],"poorly":[57],"immunogenic":[58,78],"tumor,":[59],"the":[60,185,199,205,253,267,325,385],"frequency":[61],"breadth":[63],"antigen":[66,280,371],"reactivity":[67,281,372],"patients":[70,136,168,206,215,226,232,242,287,380],"unclear.":[72],"Methods:":[73],"We":[74,109,144],"utilized":[75],"novel":[76],"programmable":[77],"mRNA":[79,272,376],"nanoparticle":[80,374],"platform":[81],"created":[83],"formulations":[84],"encoding":[85],"range":[87,103],"full-length":[89],"prostate":[90,378],"TAAs":[91,105,294,330,340],"(TAAmRNA)":[92],"systemically":[94],"study":[95],"T":[96,149,172,187],"cell":[97,150,173,188],"responses":[99,174,190,201,338],"across":[101,282],"patients.":[108,143],"administered":[110],"8":[111],"TAAmRNAs":[113],"(NY-ESO-1,":[114],"HK2,":[115],"STEAP1,":[116],"TMPRSS2-ERG,":[117],"PAP,":[118],"PSA,":[119],"PSCA":[120],"PSMA)":[122],"in-vitro":[124],"cultured":[125],"peripheral":[126],"blood":[127],"mononuclear":[128],"cells":[129],"(PBMC)":[130],"from":[131],"43":[132],"treatment-na\u00efve":[133],"localized":[134],"compared":[137],"17":[139],"age-matched":[140],"non-cancer":[141],"control":[142,268],"assessed":[145],"upregulation":[146],"early":[148],"activation":[151],"markers":[152],"interferon-gamma":[154],"(INFg)":[155],"cytokine":[156],"production":[157,236],"through":[158],"flow":[159],"cytometry":[160],"ELISPOT,":[162],"respectively.":[163],"Results:":[164],"20%":[165],"possessed":[169],"TAA-specific":[170],"CD8+":[171],"at":[176,191],"least":[177],"one":[178],"antigen.":[179],"NY-ESO-1,":[180],"HK2":[181,251],"TMPRSS2-ERG":[183],"had":[184],"highest":[186,254],"recall":[189],"average":[193],"35%,":[195],"with":[196,222,239,373],"NY-ESO-1":[197],"demonstrating":[198],"strongest":[200],"per":[202],"patient.":[203],"Of":[204],"that":[207,315],"respond":[208],"any":[210],"given":[211],"TAA,":[212],"47%":[213],"responded":[216],"three":[218,246],"or":[219,247],"more":[220,248,332],"antigens,":[221],"11%":[223],"responding":[227],"all":[229],"TAAs.":[230],"also":[233,307],"showed":[234],"heightened":[235],"IFNg,":[238],"35%":[240],"showing":[243],"pan-responsiveness":[244,291],"antigens.":[249],"Particularly,":[250],"stimulated":[252],"levels":[255,260],"INFg":[257],"production.":[258],"These":[259,305],"responsiveness":[262],"are":[263,341],"not":[264],"seen":[265],"cohort.":[269],"Conclusions:":[270],"Encapsulated":[271],"nanoparticles":[273],"can":[274,316,345],"used":[276],"systematically":[278],"map":[279],"cohort":[284],"reveal":[289,308],"frequent":[290],"multiple":[293],"what":[296],"has":[297],"considered":[298],"immunologically":[302],"cold":[303],"results":[306],"hierarchy":[310],"immunogenicity":[312,326],"candidates":[314],"enable":[317],"future":[318],"vaccine":[319],"development.":[320],"Continual":[321],"efforts":[322],"assess":[324],"advanced":[333],"disease,":[334],"how":[336],"patient":[337],"modulated":[342],"by":[343],"immunotherapies,":[344],"aid":[346],"refining":[348],"combinatorial":[349],"for":[351,388],"PC.":[352],"Citation":[353],"Format:":[354],"Elena":[355],"Montauti,":[356],"Ole":[357],"Haabeth,":[358],"Chris":[359],"Rae,":[360],"Samuel":[361],"Deutsch,":[362],"Lawrence":[363],"Fong,":[364],"David":[365],"Oh.":[366],"Mapping":[367],"encapsulated":[375],"[abstract].":[381],"In:":[382],"Proceedings":[383],"American":[386],"Association":[387],"Cancer":[389,409],"Research":[390],"Annual":[391],"Meeting":[392],"2023;":[393],"Part":[394],"2":[395],"(Clinical":[396],"Trials":[397],"Late-Breaking":[399],"Research);":[400],"2023":[401],"Apr":[402],"14-19;":[403],"Orlando,":[404],"FL.":[405],"Philadelphia":[406],"(PA):":[407],"AACR;":[408],"Res":[410],"2023;83(8_Suppl):Abstract":[411],"nr":[412],"LB346.":[413]},"counts_by_year":[],"updated_date":"2026-10-12T09:40:04.860316","created_date":"2023-04-15T00:00:00"}